Microscopy

Aiforia partners with Pathan to bring artificial intelligence assisted diagnostics to the pathology lab

Thursday, January 21, 2021 - 2:30pm

BOSTON, Jan. 21, 2021 /PRNewswire/ -- Pathan, one of the largest pathology laboratories in the Netherlands, has started a collaboration with Aiforia, a leading software company providing artificial intelligence (AI) solutions for medical image analysis.

Key Points: 
  • BOSTON, Jan. 21, 2021 /PRNewswire/ -- Pathan, one of the largest pathology laboratories in the Netherlands, has started a collaboration with Aiforia, a leading software company providing artificial intelligence (AI) solutions for medical image analysis.
  • Meanwhile the methods these healthcare professionals currently rely on are manual, sometimes time-consuming, and subject to a certain degree of bias.
  • After adopting digital pathology in their lab to digitize their analysis, they are ready to add artificial intelligence to this workflow to optimize their output.
  • Artificial intelligence excels at image analysis, with the potential to surpass human capabilities in speed and accuracy.

Amsterdam UMC adds digital pathology to its existing Sectra solution to enable integrated diagnostics for better cancer care

Thursday, January 21, 2021 - 7:50am

With radiology and pathology in one joint solution, Amsterdam UMC will be able to conveniently share images and information between the two medical specialties, enabling efficient integrated diagnostics and improved patient-centric care.

Key Points: 
  • With radiology and pathology in one joint solution, Amsterdam UMC will be able to conveniently share images and information between the two medical specialties, enabling efficient integrated diagnostics and improved patient-centric care.
  • "It's exciting to see how Amsterdam UMC, in just a short time, has taken these steps toward radiology and pathology efficiency, regional collaboration and integrated diagnostics.
  • One of the main benefits of digitizing pathology is the ability to share digital images, rather than sending physical slides back and forth.
  • Sectra's digital pathology solution will be integrated with the laboratory information system (LIS) used at Amsterdam UMC.

Global Optical Microscopes Market to Grow by $ 557.96 Million During 2020-2024 | Integration of AI and Machine Learning to be Key Trend | Technavio

Tuesday, January 19, 2021 - 1:18pm

The optical microscopes market is poised to grow by USD 557.96 million during 2020-2024, progressing at a CAGR of almost 5% during the forecast period.

Key Points: 
  • The optical microscopes market is poised to grow by USD 557.96 million during 2020-2024, progressing at a CAGR of almost 5% during the forecast period.
  • View the full release here: https://www.businesswire.com/news/home/20210119005602/en/
    Technavio has announced its latest market research report titled Global Optical Microscopes Market 2020-2024 (Graphic: Business Wire)
    Get FREE Sample Report in Minutes!
  • The report on the optical microscopes market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • This study identifies the integration of AI and machine learning into optical microscopes as one of the prime reasons driving the optical microscopes market growth during the next few years.

Flow Imaging Microscopy/Dynamic Image Analysis Market worth $45 million by 2025 - Exclusive Report by MarketsandMarkets™

Tuesday, January 19, 2021 - 12:30pm

Moreover, the rapidly growing pharmaceutical industry in emerging countries are some of the other major factors driving the growth of this dynamic image analysis market.

Key Points: 
  • Moreover, the rapidly growing pharmaceutical industry in emerging countries are some of the other major factors driving the growth of this dynamic image analysis market.
  • The North American region accounted for the largest share of the flow imaging microscopy market in 2019.
  • The North American region accounted for the largest share of the flow imaging microscopy market in 2019.
  • Particle Size Analysis Market by Technology (Laser Diffraction, DLS, Static, Dynamic Imaging, Coulter Principle, Nanoparticle Tracking), Dispersion, End-User (Pharmaceutical, Chemical, Petroleum, Mining, Food, Academia), Region - Global Forecast to 2025

Flow Imaging Microscopy/Dynamic Image Analysis Market worth $45 million by 2025 - Exclusive Report by MarketsandMarkets™

Tuesday, January 19, 2021 - 12:30pm

Moreover, the rapidly growing pharmaceutical industry in emerging countries are some of the other major factors driving the growth of this dynamic image analysis market.

Key Points: 
  • Moreover, the rapidly growing pharmaceutical industry in emerging countries are some of the other major factors driving the growth of this dynamic image analysis market.
  • The North American region accounted for the largest share of the flow imaging microscopy market in 2019.
  • The North American region accounted for the largest share of the flow imaging microscopy market in 2019.
  • Particle Size Analysis Market by Technology (Laser Diffraction, DLS, Static, Dynamic Imaging, Coulter Principle, Nanoparticle Tracking), Dispersion, End-User (Pharmaceutical, Chemical, Petroleum, Mining, Food, Academia), Region - Global Forecast to 2025

Seres Therapeutics to Present SER-109 Phase 3 Mechanistic Data at Keystone Symposium

Tuesday, January 19, 2021 - 12:00pm

The data presentation, entitled Microbiome therapeutics to treat bacterial infections and inflammatory disease, will take place virtually at the Keystone Symposium Harnessing the Microbiome for Disease Prevention and Therapy on January 20, 2021.

Key Points: 
  • The data presentation, entitled Microbiome therapeutics to treat bacterial infections and inflammatory disease, will take place virtually at the Keystone Symposium Harnessing the Microbiome for Disease Prevention and Therapy on January 20, 2021.
  • The new study data examined the pharmacokinetics (i.e., drug bacterial species engraftment) and pharmacodynamics (i.e., metabolic changes) following SER-109 dosing.
  • Notably, data demonstrated a significant decrease in primary bile acids and an increase in secondary bile acids.
  • Since Seres founding, the Company has invested in building proprietary capabilities to enable generation of detailed scientific data from clinical samples, as illustrated by these results.

Global Human Microbiome Therapeutics Market Report 2020: COVID-19 Pandemic has Decreased Short-term Potential Growth Opportunities

Monday, January 18, 2021 - 3:45pm

DUBLIN, Jan. 18, 2021 /PRNewswire/ -- The "Human Microbiome Therapeutics Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 18, 2021 /PRNewswire/ -- The "Human Microbiome Therapeutics Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.
  • Factors that could hinder the growth of the human microbiome therapeutics market in the future include ethical issues associated with the market.
  • The infectious diseases market was the largest segment of the human microbiome therapeutics market segmented by disease, accounting for 70.9% of the total in 2030.
  • Market-trend-based strategies for the human microbiome therapeutics market include investing in the strategic collaboration and research and development of microbiome therapeutics for treating cancers.

Luxel enters license agreement with Harvard to commercialize GridTape®

Monday, January 18, 2021 - 1:15pm

FRIDAY HARBOR, Wash., Jan. 18, 2021 /PRNewswire/ --Luxel Corporation announced today that it has entered into an exclusive license agreement with Harvard University to manufacture and commercialize GridTape for research purposes.

Key Points: 
  • FRIDAY HARBOR, Wash., Jan. 18, 2021 /PRNewswire/ --Luxel Corporation announced today that it has entered into an exclusive license agreement with Harvard University to manufacture and commercialize GridTape for research purposes.
  • Initially developed by connectomics researchers led by Wei-Chung Lee, PhD, at Harvard Medical School, GridTape will be a key component of Luxel's new high-volume serial section transmission electron microscopy (TEM) imaging platform with nanometer-scale resolution.
  • The license agreement was facilitated by Harvard's Office of Technology Development.
  • Luxel is the world leader in producing freestanding films ranging from 5 nanometers to several microns.

Global Human Microbiome Therapeutics Market Opportunities and Strategies to 2030 with COVID-19 Impacts, Growth and Changes - ResearchAndMarkets.com

Friday, January 15, 2021 - 5:31pm

The "Human Microbiome Therapeutics Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Human Microbiome Therapeutics Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.
  • Factors that could hinder the growth of the human microbiome therapeutics market in the future include ethical issues associated with the market.
  • The infectious diseases market was the largest segment of the human microbiome therapeutics market segmented by disease, accounting for 70.9% of the total in 2030.
  • Market-trend-based strategies for the human microbiome therapeutics market include investing in the strategic collaboration and research and development of microbiome therapeutics for treating cancers.

Healthcare region pioneering digital pathology reviews in Denmark with Sectra--aims to significantly shorten cancer turn-around times

Thursday, January 14, 2021 - 7:50am

For the Region of Southern Denmark to move to full-scale digital pathology is a milestone for cancer care in Denmark as it is key to meeting the ambitions for shorter lead times set by the national cancer care pathways," says Sune Henriksen, President, Sectra Denmark.

Key Points: 
  • For the Region of Southern Denmark to move to full-scale digital pathology is a milestone for cancer care in Denmark as it is key to meeting the ambitions for shorter lead times set by the national cancer care pathways," says Sune Henriksen, President, Sectra Denmark.
  • The Region of Southern Denmark is the first Danish healthcare region to digitize pathology in full scale.
  • With Sectra's digital pathology solution, resource utilization and sub-specialization can be optimized at the region's four geographically dispersed hospitals.
  • This enables the region to provide all patients with equal access to healthcare services, regardless of their location.